Protection from the nephrotoxicity of contrast dye

Renal Failure

Volumn 18, Issue 4, 1996, Pages 639-646

  Louis, Bertin M ^a   Hoch, Brian S ^a   Hernandez, Cecilio ^a   Namboodiri, Neel ^a   Neiderman, George ^a   Nissenbaum, Alan ^a   Foti, Francis P ^a   Magno, Angelo ^a   Banayat, Geronimo ^a   Fata, Farid ^a   Manohar, Namala L ^a   Lipner, Henry I ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ACUTE KIDNEY FAILURE; AGED; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CONTRAST ENHANCEMENT; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 9544229683     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229609047689     Document Type: Conference Paper

References (48)

1. Anto HR, Chou S-Y, Porush JG, and Shapiro WB: Infusion intravenous pyelography and renal function. Arch Intern Med 141:1652-1656, 1981.
2. Barrett BJ: Contrast Nephrotoxicity. J Am Soc Nephrol 5:125-137, 1994.
3. Barrett BJ, and Carlisle EJ: Metaanlysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171-178, 1993.
4. Barrett BJ, and Parfrey PS: Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 331:1449-1450, 1994.
5. Barrett BJ, Parfrey PS, Vavasour HM, McDonald J, Kent G, Hefferton D, O'Dea F, Stone E, Reddy R, and McManamon PJ: Contrast nephropathy in patients with impaired renal function: High versus low osmolar media. Kidney Int 41:1274-1279, 1992.
6. Barrett BJ, Parfrey PS, Vavasour HM, O'Dea F, Kent G, and Stone E: A comparison of nonionic, low-osmolality radiuocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med 326:431-436, 1992.
7. Benz RL, Teehan BP, Sigler MH, Gilgore GS, and Schleifer CR: Suppression of renal vein renin profiles by mannitol prophylaxis: implications in the evaluation of renovascular hypertension. Am J Kidney Dis 18:649-654, 1991.
8. Berns, AS: Nephrotoxicity of contrast media. Kidney Int 36:730-740, 1989.
9. Berns JS, and Rudnick MR: Radiocontrast media associated nephrotoxicity. Kidney 24:1-4, 1992.
10. Brezis M, and Epstein FH: A closer look at radiocontrast-induced nephropathy. N Engl J Med 320:179-181, 1989.
11. Cantley LG, Spokes K, Clark B, McMahon EG, Carter J, and Epstein FH: Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 44:1217-1223, 1993.
12. Cedgard S, Herlitz H, Geterud K, Attman P-O, and Aurell M: Acute renal insufficiency after administration of low-osmolar contrast media. Lancet 2:1281, 1986.
13. Cigarroa RG, Lange RA, Williams RH, and Hillis LD: Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86:649-652, 1989.
14. Conlon PJ, and Schwab SJ: Time to abandon nonionic contrast? J Am Soc Nephrol 5:123-124, 1994
15. Davidson CD, Hlatky M, Morris KG, Pieper K, Skelton TN, Schwab SJ, and Bashore TM: Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. Ann Intern Med 110:119-124, 1989.
16. Deray G, Martinez F, Cacoub P, Baumelou B, Baumelou A, and Jacobs C: A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol 10:316-322, 1990.
17. Epstein M: Calcium antagonists and the kidney. implications for renal protection. Kidney Int 41(Suppl 36):S66-S72, 1992.
18. Erley CM, Duda SH, Schlepckow S, Koehler J, Huppert PE, Strohmaier WL, Bohle A, Risler T, and Osswald H: Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int 45:1425-1431, 1994.
19. Fairley S, and Ihle BU: Thrombotic microangiopathy and acute renal failure associated with artenography. Br Med J 293:922-923, 1986.
20. Finger MA, and Ramsay A: Contrast nephropathy. Am Fam Phys 35:71-75, 1987.
21. Fontanarosa PB: Radiologic contrast-induced acute renal failure. Genitourinary Emergencies 6:601-616, 1988.
22. Gomes AS, Lois JF, Baker JD, McGlade CT, Bunnell DH, and Hartzman S: Acute renal dysfunction in high-risk patients after angiography: Comparison of ionic and nonionic contrast media. Radiology 170:65-68, 1989.
23. Harris KG, Smith TP, Cragg AH, and Lemke JH: Nephrotoxicity from contrast material in renal insufficiency: Ionic versus nonionic agents. Radiology 179:849-852, 1991.
24. Heyman SN, Clark BA, Kaiser N, Spokes K, Rosen S, Brezis M, and Epstein FH: Radiocontrast agents induced endothelin release in vivo and in vitro. J Am Soc Nephrol 1992 3:58-65, 1992.
25. Hirshfeld, Jr JW: Low-osmolarity contrast agents - who needs them? N Engl J Med 326:482-484, 1992.
26. Holland MD, Galla JH, Sanders PW, and Luke RG: Effect of urinary pH and diatrizoate on Bence Jones protein nephrotoxicity in the rat. Kidney Int 27:46-50, 1985.
27. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, Lautin JL, Braha S, Kadish EG, Sprayregen S, and Belizon I: Radiocontrast-associated renal dysfunction: Incidence and risk factors. Am J Roentgenol 157:49-58, 1991.
28. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, Lautin JL, Braha S, Kadish EG, Sprayregen S, and Belizon I: Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media. Am J Roentgenol 157:59-65, 1991.
29. Manske CL, Sprafka JM, Strony JT, and Wang Y: Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89:615-620, 1990.
30. Margulies KB, Hildebrand FL, Heublein DM, and Burnett Jr JC: Radiocontrast increases plasma and urinary endothelin. J Am Soc Nephrol 2:1041-1045, 1991.
31. McCarthy CS, and Becker JA: Multiple myeloma and contrast media. Radiology 183:519-521, 1992.
32. Moore RD, Steinberg EP, Powe NR, Brinker JA, Fishman EK, Graziano S, and Gopalan R: Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 182:649-655, 1992.
33. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, and McManamon PJ: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency or both. N Engl J Med 320:143-149, 1989.
34. Porter GA: Contrast-associated nephrotoxicity. Am J Cardiol 64:22E-26E, 1989.
35. Porter GA: Experimental contrast-associated nephropathy and its clinical applications. Am J Cardiol 66:18F-22F, 1990.
36. Rich MW, and Crecelius CA: Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 150:1237-1242, 1990.
37. Rudnick MR, Berns JS, Cohen RM, and Goldfarb S: Nephrotoxic risk of renal angiography: contrast media-associated nephrotoxicity and atheroembolism - A critical review. Am J Kidney Dis 24:713-727, 1994.
38. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, and VanFossen DB : Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 47:254-261, 1995.
39. Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TN, and Bashore TM: Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 320:149-153, 1989.
40. Solomon R, Werner C, Mann D, D'Elia J and Silva P: Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416-1420, 1994.
41. Steinberg EP, Moore RD, Powe NR, Gopalan R, Davidoff AJ, Litt M, Graziano S, and Brinker JA: Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl J Med 326:425-430, 1992.
42. Taliercio CP, McCallister SH, Holmes DR, Ilstrup DM, and Vlietstra RE: Nephrotoxicity of nonionic contrast media after cardiac angiography. Am J Cardiol 64:815-816, 1989.
43. Taliercio CP, Vlietstra RE, Fisher LD, and Burnett JC: Risks for renal dysfunction with cardiac angiography. Ann Intern Med 104:501-504, 1986.
44. Vari RC, Natarajan LA, Whitescarver SA, Jackson BA, and Ott CE: Induction, prevention and mechanisms of contrast media-induced renal failure. Kidney Int 33:699-707, 1988.
45. Weinrauch LA, Healy RW, Leland, Jr. OS, Goldstein HH, Kassissieh SD, Libertino JA, Takacs FJ, and D'Elia JA: Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann Intern Med 86:56-59, 1977.
46. Weisberg LS, Kurnik PB, and Kurnik BRC: Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction. Kidney Int 41:1408-1415, 1992.
47. Weisberg LS, Kurnik PB, and Kurnik BRC: Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 45:259-265, 1994.
48. Yoshioka T, Fogo A, and Beckman JK: Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 41:1008-1015, 1992.